Bo Ahrén
341 – 350 of 398
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.
(
- Contribution to journal › Letter
-
Mark
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Altered beta-Cell Distribution of pdx-1 and GLUT-2 After a Short-Term Challenge With a High-Fat Diet in C57BL/6J Mice.
(
- Contribution to journal › Article
-
Mark
Reduced leptin concentrations in subjects with type 2 diabetes mellitus in Sudan.
(
- Contribution to journal › Article
-
Mark
Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice
(
- Contribution to journal › Article
-
Mark
The neuropeptide PACAP contributes to the glucagon response to insulin-induced hypoglycaemia in mice.
(
- Contribution to journal › Article
-
Mark
Differential impairment of glucagon responses to hypoglycemia, neuroglycopenia, arginine, and carbachol in alloxan-diabetic mice.
(
- Contribution to journal › Article
-
Mark
Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women.
(
- Contribution to journal › Article
-
Mark
Interleukin-6-deficient mice develop mature-onset obesity
(
- Contribution to journal › Article
-
Mark
Adrenal incidentaloma - experience of a standardized diagnostic programme in the Swedish prospective study.
(
- Contribution to journal › Article